Industry 4.0 digital transformation conference: Has the pandemic accelerated digital transformation?

Michael Rinker, Chaitanya Khare, Sachin Padhye, Katie Fayman
{"title":"Industry 4.0 digital transformation conference: Has the pandemic accelerated digital transformation?","authors":"Michael Rinker,&nbsp;Chaitanya Khare,&nbsp;Sachin Padhye,&nbsp;Katie Fayman","doi":"10.1002/amp2.10075","DOIUrl":null,"url":null,"abstract":"<p>AIChE's Advanced Manufacturing and Processing Society held its second annual “Industry 4.0 Digital Transformation Conference” on December 8. The premise of this year's virtual conference was to focus on how COVID-19 has disrupted manufacturing operations and supply chains across the US and globally. This conference explored the role of digital transformation and how that impacted manufacturing during the early days of the pandemic, how manufacturers reacted, and what the future may hold for manufacturing and continued digitalization. These topics were underpinned by a key note talk from 3 M on manufacturing of personal protective equipment (PPE) and a presentation by Sandoz, a Novartis company and how they have embraced the digital transformation in pharmaceutical development. There were two panel sessions that addressed questions about how digital transformation was accelerated during the onset of the pandemic and what the future will hold for ongoing digital transformation. Finally, a digital transformation roadmap discussion and short workshop were held to complete the conference.</p><p>A summary of each session follows.</p><p>Dr. Cristina Thomas's introduction of 3 M told us about a striking feature of innovation: “Curiosity is just the beginning.” As a major global company, 3 M has sales in nearly every country on the planet. They have recent sales of approximately $32 billion, employ over 96 000 people and have over 120 000 patents. 3-M has four business groups: Safety and Industrial, Transportation and Electronics, Healthcare, and Consumer. Those groups have been working together to address challenges resulting from the pandemic. While most people heard about the challenges of ramping up production for N95 respirators, 3 M also ramped up production of other solutions in response to COVID-19, for example, sanitizers and disinfectants.</p><p>One important aspect that 3 M works on is biopharmaceutical filtration. 3 M works with public-private manufacturing institutes like Manufacturing USA's RAPID. The current situation put biopharmaceutical filtration at the center for using the surface modification technology of membranes into speeding up the development of vaccines as well as therapies.</p><p>Digital platforms that are in use at 3-M include: Computer vision, Data science, Electronic systems, Modeling &amp; Simulation, Advanced robotics, Sensors, and Software solutions. These digital capabilities augment material science and domain expertise.</p><p>The corporate research systems laboratory has five strategic platforms: Internet of Things (IOT), Edge Computing, Artificial Intelligence (AI), Modeling &amp; Simulation, Visualization &amp; Perception, and Data.</p><p>Dr. Vijay Rajamini of 3 M provided additional discussion regarding their PPE manufacturing response. There has been a tremendous surge for digital solutions to respiratory PPE challenges during the pandemic. Visualization as well as sharing of knowledge transfer of data and analytics were critical for 3 M respiratory product solutions. 3 M utilized their pre-existing emergency response planning that was implemented early on during the pandemic for respirator manufacturing. For example, they were able to ramp up N95 respirator manufacturing at different locations and manufactured over 2 billion N95 respirators. Because of the unprecedented scale of the pandemic, 3 M adapted by using modeling and simulation to accelerate innovation and scale up.</p><p>Additionally, 3 M collaboration with other companies has markedly increased with over 1100 external collaboration requests since March. As an organization, they have been surprised at the extent of collaboration efforts.</p><p>It was clear from the talk that at 3 M digital platforms are critical to deliver solutions that advance every company, enhance every home, and improve every life.</p><p>This panel session worked through several aspects of how the country and manufacturers responded to the pandemic with an emphasis on the impacts of digital transformations that were necessary in order to survive. The panelists described the manufacturing mindset that changed as the pandemic changed many things about how they were doing business. There were many companies and other organizations that utilized their manufacturing equipment and digital capabilities to transform their facility to support the immediate needs around PPE and other essentials that became scarce due to disruption. In some of those cases, the adjustments in strategy allowed companies to “survive” and not shut down during the early stages of the crisis. There was also a general paradigm shift related to the way people could work in a manufacturing environment in a safe manner, and there were digital solutions that helped to lead the way. For example, the fact that we have virtual meetings/communications now allowed the “buddy system” in manufacturing and processing facilities to be modified such that one person could go into the area with a helmet camera that their “buddy” who was located remotely, could still be there virtually so that the plant could operate. Other digital solutions allowed for modifications to building HVAC system controls for air flow and filtration to meet new safety challenges.</p><p>The panel addressed questions about supply chain disruptions and whether local/regional solutions would alleviate those disruptions. Many companies quickly started diversification of their supply chains in order to alleviate challenges of getting needed materials. Many companies worked at increasing their inventory because they found that “Just-In-Time” delivery risks were on the rise. Localization of manufacturing and suppliers was carefully considered by manufacturers from the perspective of understanding where COVID-19 outbreaks would occur and whether there would be an impact to workers (for localized outbreaks) or deliveries.</p><p>Questions were asked about data sharing during the pandemic. And while data sharing is certainly of high value between a manufacturer and their suppliers, there is ongoing concern from suppliers that their data is not shared with another supplier in order to retain a competitive edge. Data security is an ongoing challenge that will need ongoing attention.</p><p>The panel also addressed workforce and skill issues related to accelerated digital transformation that occurred for many manufacturers, especially for small and medium-sized manufacturers. There is clearly a skills gap for workers who have the manufacturing and operational expertise but not necessarily the Informational Technology (IT) skills or vice versa.</p><p>Dr. Subodh Deshmukh, Head of Product Development, Sandoz, a Novartis company, spoke about how the pandemic is accelerating drug development. It was noted that while existing drugs such as dexamethasone and remdesvir are being repurposed for COVID-19, other drugs are being developed with an AI approach to target potential COVID-19 therapies. This is pushing the frontier in drug development.</p><p>There was an explanation of the details on new drug development and how the digital transformation is utilized across the industry. Novartis strives to reimagine drug development using data and digital technology. Digital transformation is affecting all aspects of their business. It goes beyond R&amp;D, to disrupting markets, affecting supply chains, manufacturing and people practices, and most importantly cultural change. Novartis had already started on this journey and hence they had a good baseline to utilize when COVID-19 hit. The company wants to leverage knowledge of human biology and the power of computing to find better medicines. With this digital approach, there are three focus areas: Innovate, Operate, and Engage.</p><p>A little more than a decade ago, the United States government started an initiative that would later be known as the Manufacturing USA Network. Manufacturing USA is made up of 16 public-private institutes—1 sponsored by U.S. Department of Commerce, 6 sponsored by the department of Energy, and 9 sponsored by the department of defense. The institutes are membership-based organizations that have collectively brought together nearly 2000 organizations representing manufacturers of all sizes, academia, technology providers, startup organizations, government entities, and more. Each institute focuses on a specific advanced manufacturing technology area but works toward the same high-level goal: to secure America's future through manufacturing innovation, education, and collaboration.</p><p>The Industry 4.0 Digital Transformation Conference convened three Manufacturing USA representatives, Kym Wehrle from MxD, Ignasi Palou-Rivera from RAPID, and Jim Davis from CESMII, and asked them to make predictions about where the future of manufacturing is heading after the COVID-19 crisis.</p><p>Panelists unanimously agreed that supply chain visibility will be a critical asset in manufacturing for years to come, but there is still a significant amount of work to be done in this space. Some industries, particularly the consumer packaged goods and pharmaceutical companies, saw a dramatic uptick in demand during the pandemic; other industries, such as aerospace and defense, remained consistent with pre-COVID-19 demand. However, every industry faced challenges in meeting the needs of their production because of supply chain disruptions. Leveraging digital solutions to increase the visibility and transparency throughout the supply chain will help manufacturers avoid similar challenges in the future.</p><p>Data sharing also came up quite a few times among our experts. Data sharing will undoubtedly be a staple of the future of manufacturing. At present, it seems that many manufacturers are still trying to master the collection of data, ensuring that they are collecting the “right” data in their operations. From there, manufacturers need to transfer their data into a contextual and useable format for it to provide more insightful analytics.</p><p>Finally, panelists are confident that the future of manufacturing—from design, to production, to supply chain management—will see increased digitization and increased automation. From a workforce perspective, it is critical to note that that automation and digitization will not necessarily lead to job loss, but instead a reallocation of resources into roles that are safer for workers.</p><p>Ultimately, there has been a change in attitude in the manufacturing sector. Before COVID-19, many manufacturers viewed advanced manufacturing technology as an option. Now, it seems they are beginning to view advanced manufacturing technology as a staple that will, at best, increase their effectiveness and competitiveness and, at worst, keep them afloat in the next crisis.</p><p>Dr. Ravi Kumar, Sachin Padhye, Saibal Samaddar, and Shatam Bhattacharyya from Infosys led a workshop addressing the Digital Transformation Roadmap for the process Industry. Dr. Ravi Kumar kicked off the workshop by offering a perspective on Industry 4.0. He highlighted the integration of Information Technology (IT) and Operational Technology (OT) where cyber systems are more closely aligned with physical systems. This Digital Transformation is occurring across the value chain, vertically from supply chain to manufacturing to enterprise resources planning systems and horizontally from suppliers to manufacturers to customers. Advances in cyber physical systems, equipment sensors, seamless interoperability, advanced automation and control, big data, and analytics are driving the transformation. This transformation is aligning IT, OT, and Engineering Technology (ET).</p><p>Infosys surveyed manufacturers in US, Europe, and Asia Pacific in 2015 to assess their station on the Industry 4.0 journey. Only 15% of the respondents had Industry 4.0 related strategies in place. All respondents wanted to adopt Industry 4.0 to develop connected products and services and increase efficiency. In 2017, the priority was to improve productivity performance management in manufacturing with a focus on quality management. Sustainability and energy efficiency were key areas of focus in 2018. 2019 and 2020 saw the focus shift to using remote technology for assistance, guidance, digital twins, automation, and low or no touch. COVID-19 accelerated this transformation. This has led to gains ranging from 8% to 40% in margins and efficiencies across the value chain. The World Economic Forum cites several examples in their reporting that outline these gains.</p><p>Acatech, established as the German Academy of Science and Engineering, and Infosys developed a model to measure the maturity of Industry 4.0. This model has six levels of maturity. The first two levels are computerization and connectivity and are part of Industry 3.0. The other four levels, in terms of increasing maturity, are visibility (dashboards), transparency (what, why, how), predictability (what will happen), and adaptability (self-correcting machinery). Resources, Information Systems, Organization Structure and Culture support the maturity model. Other industries such as bio pharma manufacturing have similar measures of maturity. In conclusion, manufacturers are leveraging Industry 4.0 which will result in the factories of the future, where IT-OT Integration is the foundation that generates data from the factory to improve the topline and the bottom line.</p><p>Saibal Samaddar outlined the process of Design Thinking (DT) to start and continue the Industry 4.0 journey. DT is a problem-solving approach that focuses on end user from shop floor to the C-suite. It applies human centric design to solve problems in an iterative way. DT relies on cross-functional teams to define the problem in the “empathize” stage by listing challenges. The challenges are grouped and “how might we” questions are asked to ideate solutions. Solutions are tested and prototyped and either scaled or revisited. In summary, the top challenges associated with the Industry 4.0 roadmap were assessing Returns on Investment (ROI), creating a suitable culture for adoption, and sustaining momentum. Dr. Ravi Kumar offered some insights into addressing these challenges, including designing processes for greenfield and brownfield scenarios, leveraging change management, and starting small and scaling up.</p><p><b>Chaitanya Khare:</b> Writing-original draft. <b>Sachin Padhye:</b> Writing-original draft. <b>Katie Fayman:</b> Writing-original draft.</p>","PeriodicalId":87290,"journal":{"name":"Journal of advanced manufacturing and processing","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/amp2.10075","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of advanced manufacturing and processing","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/amp2.10075","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

AIChE's Advanced Manufacturing and Processing Society held its second annual “Industry 4.0 Digital Transformation Conference” on December 8. The premise of this year's virtual conference was to focus on how COVID-19 has disrupted manufacturing operations and supply chains across the US and globally. This conference explored the role of digital transformation and how that impacted manufacturing during the early days of the pandemic, how manufacturers reacted, and what the future may hold for manufacturing and continued digitalization. These topics were underpinned by a key note talk from 3 M on manufacturing of personal protective equipment (PPE) and a presentation by Sandoz, a Novartis company and how they have embraced the digital transformation in pharmaceutical development. There were two panel sessions that addressed questions about how digital transformation was accelerated during the onset of the pandemic and what the future will hold for ongoing digital transformation. Finally, a digital transformation roadmap discussion and short workshop were held to complete the conference.

A summary of each session follows.

Dr. Cristina Thomas's introduction of 3 M told us about a striking feature of innovation: “Curiosity is just the beginning.” As a major global company, 3 M has sales in nearly every country on the planet. They have recent sales of approximately $32 billion, employ over 96 000 people and have over 120 000 patents. 3-M has four business groups: Safety and Industrial, Transportation and Electronics, Healthcare, and Consumer. Those groups have been working together to address challenges resulting from the pandemic. While most people heard about the challenges of ramping up production for N95 respirators, 3 M also ramped up production of other solutions in response to COVID-19, for example, sanitizers and disinfectants.

One important aspect that 3 M works on is biopharmaceutical filtration. 3 M works with public-private manufacturing institutes like Manufacturing USA's RAPID. The current situation put biopharmaceutical filtration at the center for using the surface modification technology of membranes into speeding up the development of vaccines as well as therapies.

Digital platforms that are in use at 3-M include: Computer vision, Data science, Electronic systems, Modeling & Simulation, Advanced robotics, Sensors, and Software solutions. These digital capabilities augment material science and domain expertise.

The corporate research systems laboratory has five strategic platforms: Internet of Things (IOT), Edge Computing, Artificial Intelligence (AI), Modeling & Simulation, Visualization & Perception, and Data.

Dr. Vijay Rajamini of 3 M provided additional discussion regarding their PPE manufacturing response. There has been a tremendous surge for digital solutions to respiratory PPE challenges during the pandemic. Visualization as well as sharing of knowledge transfer of data and analytics were critical for 3 M respiratory product solutions. 3 M utilized their pre-existing emergency response planning that was implemented early on during the pandemic for respirator manufacturing. For example, they were able to ramp up N95 respirator manufacturing at different locations and manufactured over 2 billion N95 respirators. Because of the unprecedented scale of the pandemic, 3 M adapted by using modeling and simulation to accelerate innovation and scale up.

Additionally, 3 M collaboration with other companies has markedly increased with over 1100 external collaboration requests since March. As an organization, they have been surprised at the extent of collaboration efforts.

It was clear from the talk that at 3 M digital platforms are critical to deliver solutions that advance every company, enhance every home, and improve every life.

This panel session worked through several aspects of how the country and manufacturers responded to the pandemic with an emphasis on the impacts of digital transformations that were necessary in order to survive. The panelists described the manufacturing mindset that changed as the pandemic changed many things about how they were doing business. There were many companies and other organizations that utilized their manufacturing equipment and digital capabilities to transform their facility to support the immediate needs around PPE and other essentials that became scarce due to disruption. In some of those cases, the adjustments in strategy allowed companies to “survive” and not shut down during the early stages of the crisis. There was also a general paradigm shift related to the way people could work in a manufacturing environment in a safe manner, and there were digital solutions that helped to lead the way. For example, the fact that we have virtual meetings/communications now allowed the “buddy system” in manufacturing and processing facilities to be modified such that one person could go into the area with a helmet camera that their “buddy” who was located remotely, could still be there virtually so that the plant could operate. Other digital solutions allowed for modifications to building HVAC system controls for air flow and filtration to meet new safety challenges.

The panel addressed questions about supply chain disruptions and whether local/regional solutions would alleviate those disruptions. Many companies quickly started diversification of their supply chains in order to alleviate challenges of getting needed materials. Many companies worked at increasing their inventory because they found that “Just-In-Time” delivery risks were on the rise. Localization of manufacturing and suppliers was carefully considered by manufacturers from the perspective of understanding where COVID-19 outbreaks would occur and whether there would be an impact to workers (for localized outbreaks) or deliveries.

Questions were asked about data sharing during the pandemic. And while data sharing is certainly of high value between a manufacturer and their suppliers, there is ongoing concern from suppliers that their data is not shared with another supplier in order to retain a competitive edge. Data security is an ongoing challenge that will need ongoing attention.

The panel also addressed workforce and skill issues related to accelerated digital transformation that occurred for many manufacturers, especially for small and medium-sized manufacturers. There is clearly a skills gap for workers who have the manufacturing and operational expertise but not necessarily the Informational Technology (IT) skills or vice versa.

Dr. Subodh Deshmukh, Head of Product Development, Sandoz, a Novartis company, spoke about how the pandemic is accelerating drug development. It was noted that while existing drugs such as dexamethasone and remdesvir are being repurposed for COVID-19, other drugs are being developed with an AI approach to target potential COVID-19 therapies. This is pushing the frontier in drug development.

There was an explanation of the details on new drug development and how the digital transformation is utilized across the industry. Novartis strives to reimagine drug development using data and digital technology. Digital transformation is affecting all aspects of their business. It goes beyond R&D, to disrupting markets, affecting supply chains, manufacturing and people practices, and most importantly cultural change. Novartis had already started on this journey and hence they had a good baseline to utilize when COVID-19 hit. The company wants to leverage knowledge of human biology and the power of computing to find better medicines. With this digital approach, there are three focus areas: Innovate, Operate, and Engage.

A little more than a decade ago, the United States government started an initiative that would later be known as the Manufacturing USA Network. Manufacturing USA is made up of 16 public-private institutes—1 sponsored by U.S. Department of Commerce, 6 sponsored by the department of Energy, and 9 sponsored by the department of defense. The institutes are membership-based organizations that have collectively brought together nearly 2000 organizations representing manufacturers of all sizes, academia, technology providers, startup organizations, government entities, and more. Each institute focuses on a specific advanced manufacturing technology area but works toward the same high-level goal: to secure America's future through manufacturing innovation, education, and collaboration.

The Industry 4.0 Digital Transformation Conference convened three Manufacturing USA representatives, Kym Wehrle from MxD, Ignasi Palou-Rivera from RAPID, and Jim Davis from CESMII, and asked them to make predictions about where the future of manufacturing is heading after the COVID-19 crisis.

Panelists unanimously agreed that supply chain visibility will be a critical asset in manufacturing for years to come, but there is still a significant amount of work to be done in this space. Some industries, particularly the consumer packaged goods and pharmaceutical companies, saw a dramatic uptick in demand during the pandemic; other industries, such as aerospace and defense, remained consistent with pre-COVID-19 demand. However, every industry faced challenges in meeting the needs of their production because of supply chain disruptions. Leveraging digital solutions to increase the visibility and transparency throughout the supply chain will help manufacturers avoid similar challenges in the future.

Data sharing also came up quite a few times among our experts. Data sharing will undoubtedly be a staple of the future of manufacturing. At present, it seems that many manufacturers are still trying to master the collection of data, ensuring that they are collecting the “right” data in their operations. From there, manufacturers need to transfer their data into a contextual and useable format for it to provide more insightful analytics.

Finally, panelists are confident that the future of manufacturing—from design, to production, to supply chain management—will see increased digitization and increased automation. From a workforce perspective, it is critical to note that that automation and digitization will not necessarily lead to job loss, but instead a reallocation of resources into roles that are safer for workers.

Ultimately, there has been a change in attitude in the manufacturing sector. Before COVID-19, many manufacturers viewed advanced manufacturing technology as an option. Now, it seems they are beginning to view advanced manufacturing technology as a staple that will, at best, increase their effectiveness and competitiveness and, at worst, keep them afloat in the next crisis.

Dr. Ravi Kumar, Sachin Padhye, Saibal Samaddar, and Shatam Bhattacharyya from Infosys led a workshop addressing the Digital Transformation Roadmap for the process Industry. Dr. Ravi Kumar kicked off the workshop by offering a perspective on Industry 4.0. He highlighted the integration of Information Technology (IT) and Operational Technology (OT) where cyber systems are more closely aligned with physical systems. This Digital Transformation is occurring across the value chain, vertically from supply chain to manufacturing to enterprise resources planning systems and horizontally from suppliers to manufacturers to customers. Advances in cyber physical systems, equipment sensors, seamless interoperability, advanced automation and control, big data, and analytics are driving the transformation. This transformation is aligning IT, OT, and Engineering Technology (ET).

Infosys surveyed manufacturers in US, Europe, and Asia Pacific in 2015 to assess their station on the Industry 4.0 journey. Only 15% of the respondents had Industry 4.0 related strategies in place. All respondents wanted to adopt Industry 4.0 to develop connected products and services and increase efficiency. In 2017, the priority was to improve productivity performance management in manufacturing with a focus on quality management. Sustainability and energy efficiency were key areas of focus in 2018. 2019 and 2020 saw the focus shift to using remote technology for assistance, guidance, digital twins, automation, and low or no touch. COVID-19 accelerated this transformation. This has led to gains ranging from 8% to 40% in margins and efficiencies across the value chain. The World Economic Forum cites several examples in their reporting that outline these gains.

Acatech, established as the German Academy of Science and Engineering, and Infosys developed a model to measure the maturity of Industry 4.0. This model has six levels of maturity. The first two levels are computerization and connectivity and are part of Industry 3.0. The other four levels, in terms of increasing maturity, are visibility (dashboards), transparency (what, why, how), predictability (what will happen), and adaptability (self-correcting machinery). Resources, Information Systems, Organization Structure and Culture support the maturity model. Other industries such as bio pharma manufacturing have similar measures of maturity. In conclusion, manufacturers are leveraging Industry 4.0 which will result in the factories of the future, where IT-OT Integration is the foundation that generates data from the factory to improve the topline and the bottom line.

Saibal Samaddar outlined the process of Design Thinking (DT) to start and continue the Industry 4.0 journey. DT is a problem-solving approach that focuses on end user from shop floor to the C-suite. It applies human centric design to solve problems in an iterative way. DT relies on cross-functional teams to define the problem in the “empathize” stage by listing challenges. The challenges are grouped and “how might we” questions are asked to ideate solutions. Solutions are tested and prototyped and either scaled or revisited. In summary, the top challenges associated with the Industry 4.0 roadmap were assessing Returns on Investment (ROI), creating a suitable culture for adoption, and sustaining momentum. Dr. Ravi Kumar offered some insights into addressing these challenges, including designing processes for greenfield and brownfield scenarios, leveraging change management, and starting small and scaling up.

Chaitanya Khare: Writing-original draft. Sachin Padhye: Writing-original draft. Katie Fayman: Writing-original draft.

工业4.0数字化转型大会:疫情是否加速了数字化转型?
例如,我们现在有虚拟会议/通信,这一事实允许对制造和加工设施中的“伙伴系统”进行修改,这样一个人可以带着头盔摄像头进入该区域,而他们的远程“伙伴”仍然可以虚拟地在那里,以便工厂可以运行。其他数字解决方案允许对建筑暖通空调系统的气流和过滤控制进行修改,以应对新的安全挑战。小组讨论了有关供应链中断的问题,以及本地/区域解决方案是否能减轻这些中断。许多公司迅速开始了供应链的多样化,以减轻获得所需材料的挑战。许多公司致力于增加库存,因为他们发现“准时制”的交付风险正在上升。制造商从了解COVID-19疫情可能发生的地方以及是否会对工人(对于局部疫情)或交付产生影响的角度,仔细考虑了制造和供应商的本地化。有人提出了关于大流行期间数据共享的问题。虽然制造商和供应商之间的数据共享无疑具有很高的价值,但供应商一直担心,为了保持竞争优势,他们的数据不会与另一个供应商共享。数据安全是一个持续的挑战,需要持续关注。该小组还讨论了与许多制造商,特别是中小型制造商加速数字化转型相关的劳动力和技能问题。对于具有制造和操作专业知识但不一定具有信息技术(IT)技能的工人来说,显然存在技能差距,反之亦然。诺华旗下山德士公司产品开发主管Subodh Deshmukh谈到了大流行如何加速药物开发。有人指出,虽然地塞米松和瑞德韦等现有药物正在重新用于治疗COVID-19,但正在利用人工智能方法开发其他药物,以针对潜在的COVID-19治疗方法。这推动了药物开发的前沿。会上还介绍了新药开发的细节,以及如何在整个行业中利用数字化转型。诺华致力于利用数据和数字技术重新构想药物开发。数字化转型正在影响他们业务的各个方面。它不仅涉及研发,还涉及扰乱市场、影响供应链、制造和人员实践,最重要的是文化变革。诺华已经开始了这一旅程,因此他们有一个很好的基线来利用COVID-19。该公司希望利用人类生物学知识和计算能力来寻找更好的药物。通过这种数字化方法,有三个重点领域:创新、运营和参与。十多年前,美国政府发起了一项倡议,后来被称为“美国制造网络”。美国制造业协会由16家公私机构组成,1家由美国商务部赞助,6家由能源部赞助,9家由国防部赞助。这些协会是会员制组织,汇集了近2000个组织,代表了各种规模的制造商、学术界、技术提供商、初创企业、政府实体等。每个研究所都专注于特定的先进制造技术领域,但都朝着同一个高水平目标努力:通过制造创新、教育和合作来确保美国的未来。工业4.0数字化转型会议召集了三位美国制造业代表,分别是来自MxD的Kym Wehrle、RAPID的Ignasi Palou-Rivera和CESMII的Jim Davis,并请他们预测2019冠状病毒病危机后制造业的未来走向。小组成员一致认为,供应链可见性将是未来几年制造业的关键资产,但在这一领域仍有大量工作要做。一些行业,特别是包装消费品和制药公司,在疫情期间需求急剧上升;其他行业,如航空航天和国防,与新冠疫情前的需求保持一致。然而,由于供应链中断,每个行业都面临着满足其生产需求的挑战。利用数字解决方案来提高整个供应链的可见性和透明度,将有助于制造商在未来避免类似的挑战。我们的专家之间也多次提到数据共享。毫无疑问,数据共享将成为未来制造业的主要内容。 目前看来,很多制造商似乎还在努力掌握数据的收集,确保他们在运营中收集的数据是“正确的”。在此基础上,制造商需要将数据转换为上下文和可用的格式,以便提供更有洞察力的分析。最后,小组成员相信,制造业的未来——从设计到生产,再到供应链管理——将会越来越数字化和自动化。从劳动力的角度来看,必须注意的是,自动化和数字化不一定会导致失业,而是将资源重新分配到对工人更安全的角色上。最终,制造业的态度发生了变化。在新冠肺炎之前,许多制造商将先进制造技术视为一种选择。现在,他们似乎开始把先进的制造技术视为一种主食,往好了说,这将提高他们的效率和竞争力,往坏了说,这将使他们在下一次危机中得以生存。来自Infosys的Ravi Kumar、Sachin Padhye、Saibal Samaddar和Shatam Bhattacharyya主持了一个关于流程工业数字化转型路线图的研讨会。Ravi Kumar博士通过对工业4.0的看法拉开了研讨会的序幕。他强调了信息技术(IT)和操作技术(OT)的整合,其中网络系统与物理系统更紧密地结合在一起。这种数字化转型发生在整个价值链上,垂直从供应链到制造再到企业资源规划系统,横向从供应商到制造商再到客户。网络物理系统、设备传感器、无缝互操作性、先进自动化和控制、大数据和分析技术的进步正在推动这一转型。这种转变将IT、OT和工程技术(ET)结合起来。印孚瑟斯在2015年对美国、欧洲和亚太地区的制造商进行了调查,以评估他们在工业4.0之旅中的地位。只有15%的受访者制定了与工业4.0相关的战略。所有受访者都希望采用工业4.0来开发互联产品和服务,并提高效率。2017年,重点是提高制造业的生产率绩效管理,重点是质量管理。可持续性和能源效率是2018年的重点关注领域。2019年和2020年的重点转向使用远程技术进行协助、指导、数字孪生、自动化和低触摸或无触摸。COVID-19加速了这一转变。这使得整个价值链的利润率和效率提高了8%至40%。世界经济论坛在其报告中引用了几个例子来概述这些成果。成立于德国科学与工程院的Acatech和印孚瑟斯开发了一个模型来衡量工业4.0的成熟度。这个模型有六个成熟度级别。前两个层次是计算机化和连接,是工业3.0的一部分。就成熟度而言,其他四个级别是可见性(仪表板)、透明度(什么、为什么、如何)、可预测性(将发生什么)和适应性(自我纠正机制)。资源、信息系统、组织结构和文化支持成熟度模型。生物制药等其他行业也有类似的成熟度衡量标准。总之,制造商正在利用工业4.0,这将导致未来的工厂,其中IT-OT集成是从工厂生成数据以提高收入和底线的基础。Saibal Samaddar概述了开始和继续工业4.0之旅的设计思维(DT)过程。DT是一种解决问题的方法,关注从车间到高管层的最终用户。它应用以人为中心的设计,以迭代的方式解决问题。DT依靠跨职能团队通过列出挑战来定义“共情”阶段的问题。这些挑战被分组,“我们该如何做”的问题被要求构思解决方案。对解决方案进行测试和原型化,并进行缩放或重新访问。总之,与工业4.0路线图相关的最大挑战是评估投资回报率(ROI),创建适合采用的文化,以及保持势头。Ravi Kumar博士为解决这些挑战提供了一些见解,包括为绿地和棕地方案设计流程,利用变更管理,从小做起,扩大规模。Chaitanya Khare:写作-原稿。Sachin Padhye:写作——原稿。凯蒂·费曼:写作——原稿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信